Opportunities in the pharmaceutical API manufacturing market include leveraging rising demand for complex biologics, ...
Novartis announces a new API facility in Morrisville, NC, as part of its $23bn US manufacturing expansion, boosting biopharma ...
The CDMO market is poised for growth due to rising R&D spending, increased demand for generics and biologics, patent ...
Novartis will construct an active pharmaceutical ingredient (API) facility in Morrisville, North Carolina, the company said ...
CDMO Olon is continuing its expansion binge with a deal to buy an API plant in India that supplies ingredients to Novartis. The Italian generic drug and API maker said Tuesday that it is buying an API ...
The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.
MISSISSAUGA, Ontario, April 16, 2026--(BUSINESS WIRE)--Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the ...
AstraZeneca today officially opened their new Active Pharmaceutical Ingredient (API) manufacturing facility in Dublin. This new facility demonstrates how advanced automation, AI, and innovative new ...
Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...
Pakistan’s pharmaceutical manufacturing industry is one of the country’s largest and fastest growing industries. It includes more than 650 manufacturers and accounts for approximately Rs. 748 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results